Page 11 - TD-3-4

Tumor Discovery Expert consensus of NUT carcinoma

Medical College Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan, China
30 Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University
School of Medicine, Shanghai, 200433, China
31 Department of Pathology, Sir Run Run Shaw Hospital of Zhejiang University College of Medicine & Sir Run Run Shaw Institute of Clinical
Medicine of Zhejiang University, Hangzhou, Zhejiang, China
32 Department of Oncology, The First Hospital of Shanxi Medical University, Yingze, Taiyuan, Shanxi, China
33 Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Genetic Diagnosis Center, the First Hospital of
Jilin University, Changchun, Jilin, China
34 Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical
Medical College of Lanzhou University, Lanzhou, Gansu, China
35 Department of Nuclear Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
36 USC Michelson Center Convergent Science Institute in Cancer, Los Angeles, California, United States of America
37 Department of Zoology, University of Benha, Benha, Egypt
38 Departments of Urology and Pathology and the Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan, United States of
America
39 Department of Pathology, College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, Fujian, China
40 Department of Molecular Pathology, Clinical Pathology Center, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer
Hospital, Zhengzhou, Henan, China
41 Henan International Joint Laboratory of Children’s Infectious Diseases, Children’s Hospital Affiliated to Zhengzhou University, Henan
Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, Henan, China
42 Departments of Oncology & Immunotherapy, Hebei General Hospital, Shijiazhuang, Hebei, China
43 Department of Pathology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of
Medical Sciences and Peking Union Medical College, Beijing, China
44 Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China
45 Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
46 Department of Medical Oncology, Chongqing University Cancer Hospital, Shapingba, Chongqing, China
47 Department of Pathology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Shapingba,
Chongqing, China
48 Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Box 1031, 171 21, Stockholm,
Sweden
49 Department of Trauma and Emergency Surgeon, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
50 Department of Medical Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
51 Herbert Irving Comprehensive Cancer Center, Columbia University, New York City, New York, United States of America
52 Department of Rare Tumors, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of
Medical Sciences, Taian, Shandong, China
53 Department of Pathology, São João Local Health Unit, Faculty of Medicine, Institute for Research and Innovation in Health, Institute of
Molecular Pathology and Immunology of University of Porto, Portugal
54 Zhejiang Key Laboratory of Diagnosis & Treatment Technology on Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital,
Institute of Basic Medicine and Cancer, Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Institute of Basic Medicine
and Cancer, Chinese Academy of Sciences, Hangzhou, Zhejiang, China
55 Department of Neurosurgery, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
56 Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
57 Department of Oral and Maxillofacial Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
58 Institute of Biomedicine of Seville (Instituto de Biomedicina de Sevilla), Spanish National Research Council (Consejo Superior de
Investigaciones Científicas), Seville, Spain
59 Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece
60 Department of Oncology, the third Xiangya Hospital, Central South University, Changsha, Hunan, China
61 Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
62 Department of Pathology, Medical University of Graz, Graz, Styria, Austria
63 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
64 Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
65 Department of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA
90089, USA

Volume 3 Issue 4 (2024) 3 doi: 10.36922/td.4904